Why Are Opioids Not Recommended for Small Fiber Neuropathy?
At a Glance
Long-term opioids are usually not recommended for small fiber neuropathy pain because they offer limited lasting benefit and can cause dependence, overdose, side effects, or increased pain sensitivity. Doctors often favor non-opioid treatments and a supervised plan tailored to the patient.
In this answer
4 sections
If you are living with severe, burning pain from small fiber neuropathy, it can be incredibly frustrating when a doctor refuses to prescribe opioid painkillers. It is important to know that this refusal does not mean your doctor doubts your pain is real. Instead, it reflects a growing medical consensus that for chronic nerve pain, the long-term risks of opioids generally outweigh their limited benefits.
What the Guidelines Say
When medical organizations evaluate treatments, they look for reliable evidence that a medication improves pain and daily functioning over time. The 2022 American Academy of Neurology (AAN) guidelines specifically reviewed treatments for painful diabetic neuropathy—a common cause of small fiber nerve damage—and gave a strong recommendation against the routine use of opioids [1].
While this specific guideline studied diabetic neuropathy, many doctors apply the same caution to small fiber neuropathy from other causes. This is because, across various types of chronic nerve pain, the evidence supporting opioids is very weak [2]. In clinical trials, opioids like morphine have not shown reliable, long-term meaningful benefits for nerve pain, and they often cause more side effects than other treatments [3]. Long-term opioid use in people with polyneuropathy has also been associated with higher risks of depression, physical dependence, and overdose, without actually improving the person’s ability to function [4]. Note that physical dependence (experiencing withdrawal if you stop suddenly) is a normal bodily response to long-term opioid use, which is different from opioid use disorder.
The Risk of Opioid-Induced Hyperalgesia (OIH)
A concerning, though difficult-to-diagnose, risk of using opioids for nerve pain is a phenomenon called opioid-induced hyperalgesia (OIH). While painkillers are meant to reduce pain, OIH is a paradoxical effect where opioid exposure may actually make your nervous system more sensitive to pain over time [5].
If you take opioids and experience escalating pain, pain that spreads to new areas, or a heightened sensitivity to normally light touch (allodynia), it could be a sign of OIH [5][6]. However, diagnosing OIH is complex because these symptoms can also be caused by medication tolerance, withdrawal, or simply the progression of your underlying nerve damage [7]. Because of this complexity, you should never try to diagnose OIH yourself or abruptly change your medication dose.
A Crucial Safety Note: If you are currently taking an opioid, do not stop taking it suddenly. Abruptly stopping can cause severe withdrawal symptoms and uncontrolled pain. Furthermore, if you lose your tolerance and later restart at your previous dose, you are at a much higher risk of a dangerous overdose. Any reduction in your opioid dose must be done slowly and under the close supervision of your prescribing doctor. Also, be aware of the major risks of combining opioids with alcohol, benzodiazepines, or other sedating medicines.
Preferred First-Line Medication Options
Because long-term opioids are generally not recommended, doctors prefer medications that specifically target how nerves transmit pain signals. The AAN recommends several non-opioid classes for painful diabetic neuropathy, which are also commonly used for other forms of small fiber neuropathy [1][8]:
- Gabapentinoids (e.g., gabapentin, pregabalin): These calm overactive nerves. They can be effective but may cause side effects like dizziness or daytime sedation [9].
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs, e.g., duloxetine, venlafaxine): These boost brain and spinal cord chemicals that help block pain signals. They can affect blood pressure and require careful tapering when stopped [8].
- Tricyclic Antidepressants (TCAs, e.g., amitriptyline, nortriptyline): Older medications that can help with nerve pain and sleep. They must be used cautiously, especially in older adults, due to risks of dry mouth, constipation, and heart rhythm effects [9].
- Topical Treatments: Creams or patches containing lidocaine or capsaicin can be applied directly to painful areas, providing localized relief with a lower risk of whole-body side effects.
Finding the right medication involves trial and error. There is no single sequence that works for everyone, as your doctor must consider your kidney function, age, heart health, and other medications [10].
Setting Treatment Goals and Addressing the Root Cause
When managing small fiber neuropathy, the goal of treatment is rarely to eliminate pain completely. Instead, treatment aims to reduce pain enough to meaningfully improve your sleep, mood, and daily functioning [9].
Additionally, your care team should investigate the underlying cause of your neuropathy. Treating a root cause—such as managing high blood sugar or correcting a specific autoimmune issue—can help prevent further nerve damage, even if it does not reverse the damage that has already occurred [8].
Caution: Do not self-treat with supplements without guidance. For example, while low vitamin B12 can cause neuropathy, taking too much vitamin B6 can actually cause or worsen nerve damage [11].
Along with medications, consider a multidisciplinary approach. Physical therapy, occupational therapy, sleep support, and psychological pain-management techniques can be incredibly valuable tools in regaining your quality of life.
Common questions in this guide
Why are long-term opioids usually avoided for small fiber neuropathy pain?
Can opioids make small fiber neuropathy pain worse?
Should I stop taking an opioid if it is not helping my neuropathy pain?
What non-opioid medicines are used for small fiber neuropathy pain?
What else can I do besides medication for small fiber neuropathy pain?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my specific medical history (like my kidney function and other medications), which non-opioid nerve pain medication is safest for me to try?
- 2.If the first medication we try doesn't work or causes side effects, what is our backup plan?
- 3.Have we adequately evaluated all potential underlying causes of my neuropathy, such as blood sugar issues or specific vitamin imbalances?
- 4.Can we explore non-medication strategies, such as physical therapy, topical treatments, or a multidisciplinary pain clinic, to help me function better?
- 5.If I am currently on an opioid, how can we create a safe, gradual plan to reduce my dose without causing severe withdrawal?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee.
Price R, Smith D, Franklin G, et al.
Neurology 2022; (98(1)):31-43 doi:10.1212/WNL.0000000000013038.
PMID: 34965987 - 2
PEER systematic review of randomized controlled trials: Management of chronic neuropathic pain in primary care.
Falk J, Thomas B, Kirkwood J, et al.
Canadian family physician Medecin de famille canadien 2021; (67(5)):e130-e140 doi:10.46747/cfp.6705e130.
PMID: 33980642 - 3
Morphine for chronic neuropathic pain in adults.
Cooper TE, Chen J, Wiffen PJ, et al.
The Cochrane database of systematic reviews 2017; (5()):CD011669 doi:10.1002/14651858.CD011669.pub2.
PMID: 28530786 - 4
Association of Long-term Opioid Therapy With Functional Status, Adverse Outcomes, and Mortality Among Patients With Polyneuropathy.
Hoffman EM, Watson JC, St Sauver J, et al.
JAMA neurology 2017; (74(7)):773-779 doi:10.1001/jamaneurol.2017.0486.
PMID: 28531306 - 5
Opioid-Induced Tolerance and Hyperalgesia.
Mercadante S, Arcuri E, Santoni A
CNS drugs 2019; (33(10)):943-955 doi:10.1007/s40263-019-00660-0.
PMID: 31578704 - 6
Why mu-opioid agonists have less analgesic efficacy in neuropathic pain?
Martínez-Navarro M, Maldonado R, Baños JE
European journal of pain (London, England) 2019; (23(3)):435-454 doi:10.1002/ejp.1328.
PMID: 30318675 - 7
Opioid-induced Hyperalgesia in Patients With Chronic Pain: A Systematic Review of Published Cases.
Guichard L, Hirve A, Demiri M, Martinez V
The Clinical journal of pain 2021; (38(1)):49-57 doi:10.1097/AJP.0000000000000994.
PMID: 34699405 - 8
Management of Small Fiber Neuropathy: A Clinical Perspective.
Yaukey J, Kaur D
Muscle & nerve 2026; (73(3)):380-384 doi:10.1002/mus.70086.
PMID: 41367223 - 9
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects.
Brouwer BA, de Greef BT, Hoeijmakers JG, et al.
Drugs & aging 2015; (32(8)):611-21 doi:10.1007/s40266-015-0283-8.
PMID: 26239827 - 10
Small Fiber Neuropathy.
Strand N, Wie C, Peck J, et al.
Current pain and headache reports 2022; (26(6)):429-438 doi:10.1007/s11916-022-01044-8.
PMID: 35384587 - 11
Office approach to small fiber neuropathy.
Tavee JO
Cleveland Clinic journal of medicine 2018; (85(10)):801-812 doi:10.3949/ccjm.85a.17124.
PMID: 30289758
This page explains medication risks in small fiber neuropathy for informational purposes only and does not constitute medical advice. Do not stop, start, or change an opioid or other pain medicine without guidance from your prescribing clinician.
Get notified when new evidence is published on neuropathy, small fiber.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.